|
| |
|
DR. W HAQ |
|
| |
...
|
Scientist F
Medicinal and Process Chemistry Division
Central Drug Research Institute
Chattar Manzil Palace
Lucknow 226001, UP, India
|
| |
| Phone No. |
+91-0522-2212411-18 (7
lines), Ext. 4334 (lab) |
| Fax No. |
+91-0522-2243405, 2223938 |
| E- mail |
w_haq@cdri.res.in,
haq_w59@yahoo.com |
| Educational qualifications |
M.Sc., Ph.D |
Date of Birth
|
01.07.1959
|
|
| |
| VISITS
ABROAD |
| |
|
• |
Visiting
Scientist- Nov. 1991-Feb. 1992- Dept. of Chemistry,
University of Arizona, USA |
• |
Visiting Scientist (DBT
Overseas Fellow)- Jan. 1994-Feb.19 95 Dept. of Chemistry,
University of Arizona, USA |
• |
Visiting scientist- August
22-26, 1995- Ferring Peptide Production AB, Malmo, Sweden |
• |
Visiting Investigator-
June 2003-Nov. 2004- Beckman Research Institute, Duarte,
CA, USA |
|
| |
| CURRENT
AREAS OF INTEREST |
|
•
|
Design and
synthesis of peptides and small organic molecules of therapeutic
interest |
|
|
| SELECTED
PUBLICATIONS |
| |
| • |
New acylides:
synthesis of 3-O-(?-4-oxo-2-aryl-thiazolidin-3-yl)butyryl
erythromycin A derivatives. W. Haq, Deepa
Pandey and S. B. Katti Beilstein J. Org. Chem.
4(14) 2008 (doi:10.3762/bjoc.4.14) |
| • |
Solomon VR,
Haq W, Srivastava K, Puri SK, Katti SB.
Synthesis and antimalarial activity of side chain modified
4-aminoquinoline derivatives. J Med Chem.
50, 394-8, 2007 |
| • |
Song GY, Gibson
G, Haq W, Huang EC, Srivastava T, Hollstein
M, Daftarian P, Wang Z, Diamond D, Ellenhorn JD. An MVA
vaccine overcomes tolerance to human p53 in mice and humans.
Cancer Immunol Immunother. 56, 1193-1205,
2007 |
| • |
Design, Synthesis
and Antimalarial activity of a new class of Iron chelators.
V. Raja Solomon, W. Haq, Sunil K. Puri,
Kumkum Srivastava, S.B. Katti. Medicinal Chemistry,
2, 133-8, 2006 |
| • |
Gupta CM,
Haq W. Tuftsin-bearing liposomes as antibiotic
carriers in treatment of macrophage infections. Methods
Enzymol. 391, 291-304, 2005 |
• |
Daftarian P, Sharan R,
Haq W, Ali S, Longmate J, Termini J,
Diamond DJ.Novel conjugates of epitope fusion peptides
with CpG-ODN display enhanced immunogenicity and HIV recognition.
Vaccine. 2005 May 16;23(26):3453-68. |
• |
Immunosuppressant activity
in human beta-casein fragment analogs. M. Bahattacharya,
A. Puri, R. Sahai, W. Haq, L.M. Tripathi and V.M.L. Srivastava.
Bioorganic Med. Chem. Lett. 8, 327-332,
1998. |
|
| |
| |
|
|
| |
|
| |
|